These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 9231931)

  • 1. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study.
    Punt CJ; van Herpen CM; Jansen RL; Vreugdenhil G; Muller EW; de Mulder PH
    Br J Cancer; 1997; 76(2):266-9. PubMed ID: 9231931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-alpha in patients with advanced melanoma.
    Vuoristo MS; Hahka-Kemppinen M; Parvinen LM; Pyrhönen S; Seppä H; Korpela M; Kellokumpu-Lehtinen P
    Melanoma Res; 2005 Aug; 15(4):291-6. PubMed ID: 16034308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD), and human leukocyte interferon for metastatic uveal melanoma.
    Pyrhönen S; Hahka-Kemppinen M; Muhonen T; Nikkanen V; Eskelin S; Summanen P; Tarkkanen A; Kivelä T
    Cancer; 2002 Dec; 95(11):2366-72. PubMed ID: 12436444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete remission of brain metastases in three patients with stage IV melanoma treated with BOLD and G-CSF.
    Bottoni U; Bonaccorsi P; Devirgiliis V; Panasiti V; Borroni RG; Trasimeni G; Clerico R; Calvieri S
    Jpn J Clin Oncol; 2005 Sep; 35(9):507-13. PubMed ID: 16120623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma.
    Kivelä T; Suciu S; Hansson J; Kruit WH; Vuoristo MS; Kloke O; Gore M; Hahka-Kemppinen M; Parvinen LM; Kumpulainen E; Humblet Y; Pyrhönen S
    Eur J Cancer; 2003 May; 39(8):1115-20. PubMed ID: 12736111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete responses and survival after polychemotherapy plus interferon-alpha for patients with metastatic melanoma.
    Vuoristo MS
    Melanoma Res; 1996 Aug; 6(4):331-6. PubMed ID: 8873054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with metastatic melanoma with a one day regimen of dacarbazine, vincristine, bleomycin and lomustine plus interferon-alpha.
    Vuoristo M; Gröhn P; Kumpulainen E; Korpela M
    Eur J Cancer; 1994; 30A(3):420. PubMed ID: 7515632
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term Survival of Stage IV Melanoma Patients Treated with BOLD Combination Chemotherapy and Intermediate-dose Subcutaneous Interferon-alpha.
    Mattila K; Raanta P; Lahtela V; Pyrhönen S; Koskivuo I; Vihinen P
    Anticancer Res; 2018 Nov; 38(11):6393-6397. PubMed ID: 30396963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma.
    Pyrhönen S; Hahka-Kemppinen M; Muhonen T
    J Clin Oncol; 1992 Dec; 10(12):1919-26. PubMed ID: 1280673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
    Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BOLD+interferon in the treatment of metastatic uveal melanoma: first report of active systemic therapy.
    Nathan FE; Berd D; Sato T; Shield JA; Shields CL; De Potter P; Mastrangelo MJ
    J Exp Clin Cancer Res; 1997 Jun; 16(2):201-8. PubMed ID: 9261748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intermittent interferon and polychemotherapy in metastatic melanoma.
    Vuoristo MS; Gröhn P; Kellokumpu-Lehtinen P; Kumpulainen E; Turunen M; Korpela M; Joensuu H; Tiusanen K; Nevantaus A
    J Cancer Res Clin Oncol; 1995; 121(3):175-80. PubMed ID: 7536196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic chemotherapy in the treatment of malignant melanoma.
    Lens MB; Eisen TG
    Expert Opin Pharmacother; 2003 Dec; 4(12):2205-11. PubMed ID: 14640919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dacarbazine, vincristine, bleomycin and lomustine plus natural interferon-alpha for metastatic melanoma.
    Reinhold U; Bruske T; Kreysel HW
    Eur J Cancer; 1996 Jan; 32A(1):180. PubMed ID: 8695233
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunochemotherapy with recombinant interferon-alpha 2b plus dacarbazine in the treatment of advanced malignant melanoma.
    Strojan P; Rudolf Z
    Melanoma Res; 1997 Oct; 7(5):420-7. PubMed ID: 9429226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanoma.
    York RM; Foltz AT
    Cancer; 1988 Jun; 61(11):2183-6. PubMed ID: 2452681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CD4+/CD8+ ratio as a prognostic factor in patients with metastatic melanoma receiving chemoimmunotherapy.
    Hernberg M; Muhonen T; Turunen JP; Hahka-Kemppinen M; Pyrhönen S
    J Clin Oncol; 1996 May; 14(5):1690-6. PubMed ID: 8622089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma.
    Hernberg MM; Hahka-Kemppinen MH; Pyrhönen SO
    Melanoma Res; 2004 Dec; 14(6):493-500. PubMed ID: 15577320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chemo-/immunotherapy in advanced malignant melanoma: carboplatin and DTIC or cisplatin, dtic, bcnu and tamoxifen followed by immunotherapy with interleukin 2 and interferon alpha-2a].
    Kirchner HH; Atzpodien J; Poliwoda H
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():44-9. PubMed ID: 8692119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II multicentre study of temozolomide in combination with interferon alpha-2b in metastatic malignant melanoma.
    García M; del Muro XG; Tres A; Crespo C; Valladares M; López JJ; Rifà J; Pérez X; Filipovich E; Germà-Lluch JR
    Melanoma Res; 2006 Aug; 16(4):365-70. PubMed ID: 16845333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.